In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transneuronix Inc.

Division of Medtronic PLC

Latest From Transneuronix Inc.

Device Exits Can Rival Biotech, But Watch Out for the Risks

A look at recent exits challenges the widely held view that device investments have lower return potential than biotech investments. However, a close inspection of the risk/return profile reveals that device investors are taking on more risk than ever.
Medical Device Business Strategies

Devices Treat Obesity Patients without Options

Early intervention is the general rule for success in treating many diseases, but in obesity, patients have to be in bad shape before they're eligible for the most efficacious treatments, which are surgical interventions. Companies with minimally invasive--and anatomy sparing--devices hope to change that paradigm.

The Bariatrics Boom

Over the last 20 years, obesity has become a disease of epidemic proportions, and the prevalence of this complex disease continues to rise. Amid this epidemic, opportunities abound for companies with surgical and nonsurgical solutions, making this market one of the hottest new growth areas for medical technology companies. At this year's meeting of the American Society of Bariatric Surgery (ASBS), manufacturers showcased some of the latest surgical solutions for treating obesity and the morbidly obese.
Medical Device Platform Technologies

In Search of the Perfect Earn-Out

The widening gap between expectations of pricing between the buyers and sellers of emerging medical technology companies has increased the number of earn-out transactions, all of which have been different and offered varying degrees of risk and reward. According to Richard Ferrari, a managing director of De Novo Ventures, earn-out transactions are complex and need careful consideration to ensure that they benefit both parties--a poorly structured deal can lead to opportunistic behavior by the acquirer. Ferrari discusses the four stages that define the structure of all earnout transactions
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Contact Info
  • Transneuronix Inc.
    Phone: (973) 601-1950
    100 Stierli Ct.
    Ste. 106
    Mt. Arlington, NJ 07856
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register